Clinical Proteomics: From Biomarker Discovery and Cell Signaling Profiles to Individualized Personal Therapy

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Bioscience Reports

• Publication date

  2005-02-04

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/S10540-005-2851-3PMID 16222423
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Mapping molecular networks using proteomics: a vision for patient-tailored combination therapy.

  2005influential reference
• Tyrosine kinase inhibitors and the dawn of molecular cancer therapeutics.

  2005cited by this paper
• Blasting into the Microworld of Tissue Proteomics: A New Window on Cancer

  2004cited by this paper
• Biomarker Amplification by Serum Carrier Protein Binding

  2004cited by this paper
• Single cell profiling of potentiated phospho-protein networks in cancer cells.

  2004cited by this paper
• Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cells.

  2004cited by this paper
• SELDI-TOF-based serum proteomic pattern diagnostics for early detection of cancer.

  2004cited by this paper
• MEK inhibitors: a therapeutic approach to targeting the Ras-MAP kinase pathway in tumors.

  2004cited by this paper
• c-Src and cooperating partners in human cancer.

  2004cited by this paper
• High-resolution serum proteomic features for ovarian cancer detection.

  2004cited by this paper
• Protein Profiling in Brain Tumors Using Mass Spectrometry

  2004cited by this paper
• Mining mass spectra for diagnosis and biomarker discovery of cerebral accidents

  2004cited by this paper
• Serum proteomic profiling can discriminate prostate cancer from benign prostates in men with total prostate specific antigen levels between 2.5 and 15.0 ng/ml.

  2004cited by this paper
• Lessons from Kitty Hawk: From feasibility to routine clinical use for the field of proteomic pattern diagnostics

  2004cited by this paper
• Clinical proteomics: revolutionizing disease detection and patient tailoring therapy.

  2004cited by this paper
• Proteomic approaches in cancer risk and response assessment.

  2004cited by this paper
• Imatinib as a paradigm of targeted therapies.

  2004cited by this paper
• Optimizing treatment of HER2-positive metastatic breast cancer.

  2004cited by this paper
• Use of proteomic analysis to monitor responses to biological therapies

  2004cited by this paper
• Clinical proteomics: Applications for prostate cancer biomarker discovery and detection.

  2004cited by this paper
• Molecular Profiling Provides Evidence of Primary Mediastinal Large B-Cell Lymphoma as a Distinct Entity Related to Classic Hodgkin Lymphoma: Implications for Mediastinal Gray Zone Lymphomas as an Intermediate Form of B-Cell Lymphoma

  2004cited by this paper
• Ras-induced interleukin-8 expression plays a critical role in tumor growth and angiogenesis.

  2004cited by this paper
• Biomarkers of ovarian tumours.

  2004cited by this paper
• Serum proteomics in cancer diagnosis and management.

  2004cited by this paper
• Opportunities for Nanotechnology-Based Innovation in Tissue Proteomics

  2004cited by this paper
• Protein arrays: The current state‐of‐the‐art

  2003cited by this paper
• Proteomic patterns of tumour subsets in non-small-cell lung cancer.

  2003cited by this paper
• A panel of cerebrospinal fluid potential biomarkers for the diagnosis of Alzheimer's disease

  2003cited by this paper
• Protein microarrays: Molecular profiling technologies for clinical specimens

  2003cited by this paper
• STAT5b, a Mediator of Synergism between c-Src and the Epidermal Growth Factor Receptor*

  2003cited by this paper
• Characterization of Renal Allograft Rejection by Urinary Proteomic Analysis

  2003cited by this paper
• Early detection: Proteomic applications for the early detection of cancer

  2003cited by this paper
• Proteomic profiling of the NCI-60 cancer cell lines using new high-density reverse-phase lysate microarrays

  2003cited by this paper
• Clinical applications of proteomics.

  2003cited by this paper
• Gene expression profiles of human breast cancer progression

  2003cited by this paper
• Antibody microarray profiling of human prostate cancer sera: Antibody screening and identification of potential biomarkers

  2003cited by this paper
• Clinical proteomics: Written in blood

  2003cited by this paper
• Repeated observation of breast tumor subtypes in independent gene expression data sets

  2003cited by this paper
• Signal pathway profiling of ovarian cancer from human tissue specimens using reverse‐phase protein microarrays

  2003cited by this paper
• Signal pathway profiling of prostate cancer using reverse phase protein arrays

  2003cited by this paper
• Mitochondrial proteome: Altered cytochrome c oxidase subunit levels in prostate cancer

  2003cited by this paper
• Nanoparticle-Based Bio-Bar Codes for the Ultrasensitive Detection of Proteins

  2003cited by this paper
• Molecular fingerprinting in human lung cancer.

  2003cited by this paper
• Protein microarrays: meeting analytical challenges for clinical applications.

  2003cited by this paper
• Tyrosine kinases as targets in cancer therapy – successes and failures

  2003cited by this paper
• Laser Capture Microdissection and Advanced Molecular Analysis of Human Breast Cancer

  2003cited by this paper
• Use of proteomic patterns in serum to identify ovarian cancer.

  2002cited by this paper
• Serum proteomic patterns for detection of prostate cancer.

  2002cited by this paper
• Cooperative inhibitory effect of ZD1839 (Iressa) in combination with trastuzumab (Herceptin) on human breast cancer cell growth.

  2002cited by this paper
• Gene expression profiling of lymphoid malignancies.

  2002cited by this paper
• Receptor tyrosine kinases as targets for anticancer drugs.

  2002cited by this paper
• Human genetics and disease: Beyond Mendel: an evolving view of human genetic disease transmission

  2002cited by this paper
• Proteomics and bioinformatics approaches for identification of serum biomarkers to detect breast cancer.

  2002cited by this paper
• Gene expression in ovarian cancer reflects both morphology and biological behavior, distinguishing clear cell from other poor-prognosis ovarian carcinomas.

  2002cited by this paper
• Trastuzumab: hopes and realities.

  2002cited by this paper
• Diffuse large B-cell lymphoma outcome prediction by gene-expression profiling and supervised machine learning

  2002cited by this paper
• Gene expression correlates of clinical prostate cancer behavior.

  2002cited by this paper
• Clinical proteomics: translating benchside promise into bedside reality

  2002influential reference
• Profiling of cancer cells using protein microarrays: discovery of novel radiation-regulated proteins.

  2001cited by this paper
• Ras biochemistry and farnesyl transferase inhibitors: a literature survey

  2001cited by this paper
• Reverse phase protein microarrays which capture disease progression show activation of pro-survival pathways at the cancer invasion front

  2001cited by this paper
• Clinical proteomics: personalized molecular medicine.

  2001cited by this paper
• New technologies for biomarker analysis of prostate cancer progression: Laser capture microdissection and tissue proteomics.

  2001cited by this paper
• Tyrosine kinase inhibitors: From rational design to clinical trials

  2001cited by this paper
• The microenvironment of the tumour–host interface

  2001cited by this paper
• Oncogenic kinase signalling

  2001cited by this paper
• Initial sequencing and analysis of the human genome

  2001cited by this paper
• Minimum information about a microarray experiment (MIAME)—toward standards for microarray data

  2001cited by this paper
• Laser Capture Microdissection

  2001cited by this paper
• Development of a prostate cDNA microarray and statistical gene expression analysis package

  2000cited by this paper
• The Hallmarks of Cancer Review

  2000cited by this paper
• Rapid protein display profiling of cancer progression directly from human tissue using a protein biochip

  2000cited by this paper
• Laser Capture Microdissection

  1996cited by this paper
• ras oncogenes in human cancer: a review.

  1989cited by this paper
• Mutation and cancer: a model for human carcinogenesis.

  1981cited by this paper

• Endocrine disruption in metabolic disorders: Biomarkers and therapeutic targets.

  2026cites this paper
• Harnessing the potential of reverse‐phase protein array technology: Advancing precision oncology strategies

  2024cites this paper
• Bioinformatics approach for searching for natural products in vector-borne disease management

  2024cites this paper
• ErbB2pY ‐1248 as a predictive biomarker for Parkinson's disease based on research with RPPA technology and in vivo verification

  2023cites this paper
• Perilymph metabolomic and proteomic MALDI-ToF profiling with porous silicon chips: A proof-of-concept study.

  2022cites this paper
• Utility of Reverse-Phase Protein Array for Refining Precision Oncology.

  2019cites this paper
• Reverse Phase Protein Arrays: From Technical and Analytical Fundamentals to Applications

  2019cites this paper
• Quantitative label-free mass spectrometry using contralateral and adjacent breast tissues reveal differentially expressed proteins and their predicted impacts on pathways and cellular functions in breast cancer.

  2019cites this paper
• Understanding the Pathological Basis of Neurological Diseases Through Diagnostic Platforms Based on Innovations in Biomedical Engineering: New Concepts and Theranostics Perspectives

  2018cites this paper
• Case I: 3DMed: An R&D Platform for Personalised Precision Anti-cancer Drugs

  2018cites this paper
• New Insights into the Tumor Microenvironment Utilizing Protein Array Technology

  2018cites this paper
• Signaling pathway profiling using reverse-phase protein array and its clinical applications

  2017cites this paper
• Studying the effect of microwave heating on the digestion process and identification of proteins

  2017cites this paper
• The bioefficacy of flavokawain C against colon cancer and the underlying mechanistic insights / Phang Chung Weng

  2017cites this paper
• Obesidad y análisis proteómico: su utilidad en la búsqueda de biomarcadores y blancos terapéuticos de enfermedades metabólicas

  2017cites this paper
• Stimuli-Responsive Polymer Materials for Creation of Biointerfaces

  2017cites this paper
• Application of Proteomics to Cancer Therapy

  2016cites this paper
• Functionalization and microfluidic integration of silicon nanowire biologically gated field effect transistors

  2016cites this paper
• Copolymer Brush-Based Ultralow-Fouling Biorecognition Surface Platform for Food Safety.

  2016cites this paper
• Proteomics studies in inner ear disorders: pathophysiology and biomarkers

  2015cites this paper
• Functionalizable low-fouling coatings for label-free biosensing in complex biological media: advances and applications

  2015cites this paper
• Signaling pathway profiling by reverse-phase protein array for personalized cancer medicine.

  2015cites this paper
• Nanomedicine: The Dawn of a New Era

  2015cites this paper
• Functionalized ultra-low fouling carboxy- and hydroxy-functional surface platforms: functionalization capacity, biorecognition capability and resistance to fouling from undiluted biological media.

  2014cites this paper
• Evaluation of reverse phase protein array (RPPA)-based pathway-activation profiling in 84 non-small cell lung cancer (NSCLC) cell lines as platform for cancer proteomics and biomarker discovery.

  2014cites this paper
• Comparing biomarkers and proteomic fingerprints for classification studies

  2013cites this paper
• Bioinformatics of Human Proteomics

  2013cites this paper
• Clinical Translation of Protein Biomarkers Integrated with Bioinformatics

  2013cites this paper
• A reagentless enantioselective sensor for tryptophan enantiomers via nanohybrid matrices

  2013cites this paper
• Developing tissue proteomics : differential in gel electrophoresis in biomarker discovery and proteomic degradation

  2013cites this paper
• Shotgun-proteomics-based clinical testing for diagnosis and classification of amyloidosis.

  2013cites this paper
• Analysis of protein expression profile of oral squamous cell carcinoma by MALDI-TOF-MS.

  2013cites this paper
• MALDI imaging of post‐mortem human spinal cord in amyotrophic lateral sclerosis

  2013cites this paper
• Congo Red Staining Laser Microdissection Heat-mediated Antigen Retrieval Trypsin Digestion Tandem Mass Spectrometry BioinformaticsProtein Identification Report

  2013cites this paper
• Basic principles of cord blood stem cells

  2012cites this paper
• Protein pathway activation mapping reveals molecular networks associated with antiestrogen resistance in breast cancer cell lines

  2012cites this paper
• Identification of troponin I and actin, alpha cardiac muscle 1 as potential biomarkers for hearts of electrically stimulated chickens

  2012cites this paper
• Proteomic Analysis of Cerebrospinal Fluid in a Fulminant Case of Multiple Sclerosis

  2012cites this paper
• Nanotechnology Commercialization for Managers and Scientists

  2012cites this paper
• Zwitterionic polymer-based platform with two-layer architecture for ultra low fouling and high protein loading.

  2012cites this paper
• Zwitterionic polycarboxybetaine coating functionalized with REDV peptide to improve selectivity for endothelial cells.

  2012cites this paper
• Immunoaffinity capillary electrophoresis: A new versatile tool for determining protein biomarkers in inflammatory processes

  2011cites this paper
• Systems Biology in Livestock Health and Disease

  2011cites this paper
• Caractérisation d'un modèle animal de douleur articulaire associée à l'arthrose du genou chez le rat Sprague-Dawley

  2011cites this paper
• Advancing mass spectrometry-based clinical proteomics in Saudi Arabia. Establishing a Saudi Proteomics Society.

  2011cites this paper
• Phosphoproteomic analysis of signaling pathways in head and neck squamous cell carcinoma patient samples.

  2011cites this paper
• Reverse-phase protein microarrays (RPPA) as a diagnostic and therapeutic guide in multidrug resistant leukemia.

  2011cites this paper
• The Promise of Individualized Therapy

  2010cites this paper
• How has proteomics informed transfusion biology so far?

  2010cites this paper
• UPA and PAI-1 analysis from fixed tissues - new perspectives for a known set of predictive markers.

  2010cites this paper
• Lipoic acid glyco-conjugates, a new class of agents for controlling nonspecific adsorption of blood serum at biointerfaces for biosensor and biomedical applications.

  2010cites this paper
• Analyse von Signalwegen in formalinfixierten Brustkrebsgeweben

  2010cites this paper
• Singularity analysis of the AKT signaling pathway reveals connections between cancer and metabolic diseases

  2010cites this paper
• Blood-related proteomics.

  2010cites this paper
• Deciphering signaling pathways in clinical tissues for personalized medicine using protein microarrays

  2010cites this paper
• Targeted therapies in cancer - challenges and chances offered by newly developed techniques for protein analysis in clinical tissues

  2010cites this paper
• Proteomics of Bone Cancer

  2010cites this paper
• Protein Biomarker Discovery Using Mass Spectrometry–Based Proteomics

  2010cites this paper
• Análise proteômica de carcinomas primários de mama

  2010cites this paper
• The promise of bone cancer proteomics

  2010cites this paper
• Umbilical cord blood stem cells: towards a proteomic approach.

  2010cites this paper
• Label-free detection of cancer biomarker candidates using surface plasmon resonance imaging

  2009cites this paper
• Temporally resolved differential proteomic analysis of human ventricular CSF for monitoring traumatic brain injury biomarker candidates.

  2009cites this paper
• Bioinformatics and Omics

  2009cites this paper
• Predicting the Response of Advanced Cervical and Ovarian Tumors to Therapy

  2009cites this paper
• Proteomic Signatures of Epidermal Growth Factor Receptor and Survival Signal Pathways Correspond to Gefitinib Sensitivity in Head and Neck Cancer

  2009cites this paper
• Sensitive and multiplexed detection of proteomic antigens via quantum dot aggregation.

  2009cites this paper
• Development of microdevices for proteome research and diagnosis

  2009cites this paper
• Identification, characterization and quantification of specific neuropeptides in rat spinal cord by liquid chromatography electrospray quadrupole ion trap mass spectrometry.

  2009cites this paper
• Development of microDevices for proteome research anD Diagnosis

  2009cites this paper
• Functionalizable surface platform with reduced nonspecific protein adsorption from full blood plasma--material selection and protein immobilization optimization.

  2009cites this paper
• Increase in serum haptoglobin and apolipoprotein M in patients with obstructive sleep apnoea

  2009cites this paper
• Comparative study of SPR and ELISA methods based on analysis of CD166/ALCAM levels in cancer and control human sera.

  2009cites this paper
• The expression of HLA class I molecules and complement regulatory proteins in ovarian cancer

  2008cites this paper
• Ultralow fouling and functionalizable surface chemistry based on a zwitterionic polymer enabling sensitive and specific protein detection in undiluted blood plasma.

  2008cites this paper
• Identification and quantification of metabolising enzymes in human tissue : a proteomics approach

  2008cites this paper
• The mathematical engines of nanomedicine.

  2008cites this paper
• Applications of protein microarrays for biomarker discovery

  2008cites this paper
• Proteomic and metabolomic biomarkers for III-V semiconductors: and prospects for application to nano-materials.

  2008cites this paper
• Molecular genetics of lung and pleural neoplasms

  2008cites this paper
• Quantum dot self-assembly for protein detection with sub-picomolar sensitivity.

  2008cites this paper
• Clinical proteomics in cancer research-promises and limitations of current two-dimensional gel electrophoresis.

  2008cites this paper
• Surface plasmon resonance sensors for detection of chemical and biological species.

  2008cites this paper
• The Role of the NF-kappaB Transcriptome and Proteome as Biomarkers in Human Head and Neck Squamous Cell Carcinomas.

  2008cites this paper
• A Proteomic Method For Core Needle Biopsy Sample Characterization

  2008cites this paper
• Development and validation of sandwich ELISA microarrays with minimal assay interference.

  2008cites this paper
• Designing a ligand for pharmaceutical purposes

  2008cites this paper
• The Current State of Proteomics in GI Oncology

  2008cites this paper
• Mass spectrometry in clinical treatment

  2008cites this paper
• Molecular recognition based agglomeration of quantum dot bioconjugates for multiplexed antigen detection

  2008cites this paper
• Ethical, legal and social implications of genetics

  2007cites this paper
• Use of multidimensional separation protocols for the purification of trace components in complex biological samples for proteomics analysis.

  2007cites this paper
• Novel therapeutic approaches based on the targeting of microenvironment-derived survival pathways in human cancer: experimental models and translational issues.

  2007cites this paper
• Using nutrigenomics to evaluate apoptosis as a preemptive target in cancer prevention.

  2007cites this paper
• Porous silicon surfaces – A candidate substrate for reverse protein arrays in cancer biomarker detection

  2007cites this paper
• Magneto immuno-PCR: a novel immunoassay based on biogenic magnetosome nanoparticles.

  2007cites this paper
• Identifying molecular targets for cancer therapy

  2007cites this paper
• Proteomic analysis of bone cancer: a review of current and future developments

  2007cites this paper
• Clinical application of tear proteomics: Present and future prospects

  2007cites this paper
• Analysis of signaling pathways in 90 cancer cell lines by protein lysate array.

  2007cites this paper